Malhotra V L, Khandpur N, Dass A, Mehta G
Department of Microbiology, Lady Hardinge Medical College, New Delhi.
J Commun Dis. 2008 Dec;40(4):269-72.
A total of 250 urinary isolates (188 Escherichia coli and 62 Klebsiella pneumoniae) were studied for ESBL production by double disc approximation test and disc diffusion confirmatory test (NCCLS). ESBL production was found to be 56% in E. coli and 52% in K. pneumoniae. The double disc approximation test showed false ESBL production in five (2.6%) isolates of E. coli and one (1.6%) K. pneumoniae. The susceptibility of ESBL producers to imipenem, amikacin, nitrofurantion was found to be 100%, 86% and 84% respectively. A high degree of co-resistance to co- trimaxazole and norfloxacin was found in strains of ESBL producers. Seventy five per cent of ESBL producers detected were from hospitalized patients admitted in ICU or undergoing surgery.
通过双纸片协同试验和纸片扩散确认试验(美国国家临床实验室标准化委员会方法),对总共250株尿液分离菌(188株大肠杆菌和62株肺炎克雷伯菌)进行了超广谱β-内酰胺酶(ESBL)检测。结果发现,大肠杆菌中ESBL的产生率为56%,肺炎克雷伯菌中为52%。双纸片协同试验显示,5株(2.6%)大肠杆菌分离菌和1株(1.6%)肺炎克雷伯菌分离菌出现假ESBL产生情况。ESBL产生菌对亚胺培南、阿米卡星、呋喃妥因的敏感率分别为100%、86%和84%。在ESBL产生菌菌株中发现对复方新诺明和诺氟沙星有高度的共同耐药性。检测到的ESBL产生菌中有75%来自入住重症监护病房(ICU)或正在接受手术的住院患者。